ERJ January 2018: The RESPIRE trials

ERJ January 2018: The RESPIRE trials

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews the Anthony De Soyza (Newcastle University, Newcastle, UK) and Timothy Aksamit (Mayo Clinic, Rochester, MN, USA) about the RESPIRE1 and RESPIRE2 trials of ciprofloxacin in non-cystic fibrosis bronchiectasis. These two global phase III trials enrolled a total of 937 and test two dosing regimens tested (identical dose). The range of treatment estimates favours use of a ciprofloxacin dry powder inhaler (DPI), which was overall, well tolerated, with high compliance and an excellent safety profile. The ciprofloxacin DPI 14-day regimen gave a 144-day delay in the to time to first exacerbation and a 25% reduction in the frequency of exacerbations, and the 28-day regimen gave a 138-day delay in to time to first exacerbation and a 28% reduction in frequency of exacerbations.

Avsnitt(81)

ERJ April 2018: Observing dyspnoea in others

ERJ April 2018: Observing dyspnoea in others

As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Andreas von Leupoldt (University of Leuven, Belgium) and...

19 Apr 201811min

ERJ March 2018: World TB Day

ERJ March 2018: World TB Day

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista M...

22 Mars 201815min

ERJ February 2018: Effectiveness versus efficacy

ERJ February 2018: Effectiveness versus efficacy

As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Jørgen Vestbo (The University of Manchester and Manch...

22 Feb 201811min

ERJ December 2017: An interview with the new editors

ERJ December 2017: An interview with the new editors

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert interviews the incoming Chief Editor Martin Kolb and Deputy Chi...

21 Dec 201714min

ERJ Nov 2017: ERS statement on the diagnosis and treatment of pulmonary disease caused by AATD

ERJ Nov 2017: ERS statement on the diagnosis and treatment of pulmonary disease caused by AATD

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the ERS statement on the diagnosis and treatment of p...

21 Dec 20179min

ERJ October 2017: Lessons from IPF clinical trials over the past 25 years

ERJ October 2017: Lessons from IPF clinical trials over the past 25 years

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the lessons learned from clinical trials in idiopathic...

26 Okt 201720min

ERJ September 2017: The hidden burden of severe asthma

ERJ September 2017: The hidden burden of severe asthma

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a survey of patien...

22 Sep 201711min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-spraket
rss-ufo-bortom-rimligt-tvivel-2
medicinvetarna
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
hacka-livet
sexet
rss-tidslinjen-podcast
dumforklarat
halsorevolutionen
har-vi-akt-till-mars-an
4health-med-anna-sparre
doden-hjarnan-kemisten